期刊文献+

伴有多种危险因素的冠心病患者支架内再狭窄的影响因素 被引量:4

Relevant factors for in-stent restenosis in coronary artery disease patients with multiple risk factors
原文传递
导出
摘要 目的 :分析伴有多种危险因素的冠心病患者发生支架内再狭窄(in-stent restenosis,ISR)的影响因素。方法:收集207例1年前接受冠状动脉介入治疗且伴有2个或2个以上危险因素的冠心病患者,其中100例发生ISR(ISR组),107例无ISR(对照组),分析2组患者的一般资料及实验室检查结果。结果 :ISR的发生与冠心病传统危险因素的多少无关。ISR组患者的糖尿病患病率高于对照组(51%比32%,P=0.01),而ISR组的平均体质量指数(body mass index,BMI)则低于对照组(24.90±3.16和25.91±3.53,P=0.03);同时,ISR组的尿酸[(343.79±103.40)μmol/L比(331.99±84.05)μmol/L,P=0.046]及红细胞分布宽度(red blood cell distribution width,RDW)[(13.88±1.05)%比(13.24±0.74)%,P<0.01)]水平亦均高于对照组。多元回归分析显示,糖尿病、低BMI、高RDW及糖尿病患者使用胰岛素治疗与ISR的发生间有相关性,尿酸不是ISR的独立危险因素,可能与其他危险因素相互作用从而增加了ISR的发生率。结论:糖尿病、低BMI、高RDW可能是冠心病患者发生ISR的危险因素,其中糖尿病患者的胰岛素治疗或可减少ISR的发生率。 Objective: To analyze the relevant factors of in-stent restenosis in coronary artery disease patients undergone successful percutaneous coronary intervention(PCI) one year before. Methods: The demographic and laboratory data of 207 post-PCI patients with 2 or more risk factors of coronary artery disease were retrospectively analyzed. Among these patients, 100 developed in-stent restenosis(ISR),and the remaining 107 patients without restenosis were served as the control group. Results: The incidence of ISR had no relationship with the number of risk factors for coronary heart disease. The number of diabetic patients in ISR group was more than that in control group(51% vs 32%, P=0.01), and the average body mass index(BMI) was lower in ISR group than that in control group(24.90±3.16 and 25.91±3.53, P=0.03).The uric acid level and RDW(red blood cell distribution width) level were higher in ISR group(343.79 ±103.40 vs331.99±84.05, P=0.046; 13.88±1.05 vs 13.24±0.74, P〈0.01). Logistic regression analysis showed that diabetes, low BMI,higher RDW and insulin treatment were associated with the occurrence of ISR. Conclusion: Diabetes mellitus, higher RDW and low BMI are the risk factors of ISR in coronary artery disease patients with multiple risk factors, while insulin therapy might reduce the incidence of ISR.
作者 王芳 章安迪
出处 《诊断学理论与实践》 2016年第3期280-282,共3页 Journal of Diagnostics Concepts & Practice
关键词 多种危险因素 冠心病 红细胞分布宽度 支架内再狭窄 Multiple risk factors Coronary heart disease Red blood cell distribution width In-stent restenosis
  • 相关文献

参考文献11

  • 1Wihanda D, Alwi 1, Yamin M, et al. Factors Associated with In-stent Restenosis in Patients Following Percuta- neous Coronary Intervention[J]. Acta Med Indones,2015, 47(3):209-215.
  • 2陈劲松,陈韵岱,田峰,韩运峰,荆晶,刘杰,王晶,周珊珊.冠心病合并糖尿病患者药物洗脱支架置入后2年支架内再狭窄的预测因素[J].中华心血管病杂志,2014,42(1):14-18. 被引量:14
  • 3Gilbert J, Raboud J, Zinman B. Meta-analysis of the ef- fect of diabetes on restenosis rates among patients re- ceiving coronary angioplasty stenting[J]. Diabetes Care, 2004,27(4):990-994.
  • 4Schofer J, Schltiter M, Rau T, et al. Influence of treat- ment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study[J]. J Am Coll Cardiol,2000,35(6): 1554-1559.
  • 5Fukuda N. Cigarette smoking induces vascular prolifera- tive disease through the activation of Egr-l[J]. Cardiovasc Res,2010,88(2):207-208.
  • 6West NE, Ruygrok PN, Disco CM, et al. Clinical and an- giographic predictors of restenosis after stent deployment in diabetic patients[J]. Circulation,2004,109(7):867-873.
  • 7Natarajan MK, Strauss BH, Rokoss M, et al. Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes, the STent Restenosis And Metabolism (STREAM) study[J]. Cardiovasc Revasc Med,2012,13(2):95-100.
  • 8Felker GM, Allen LA, Pocock S J, et al. Red cell distri- bution width as a novel prognostic marker in heart fai- lure: data from the CHARM Program and the Duke Data- bank[J]. J Am Coll Cardiol,2007,50(1):40-47.
  • 9Drakopoulou M, Toutouzas K, Stefanadi E, et al. Associa- tion of inflammatory markers with angiographic severity and extent of coronary artery disease[J]. Atherosclerosis, 2009,206(2):335-339.
  • 10Kurtul A, Murat SN, Yarlioglues M, et al. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease[J]. Platelets, 2015,26(1):48-52.

二级参考文献15

  • 1Serruys PW,de Jaegere P,Kiemeneij F. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease[J].New England Journal of Medicine,1994.489-495.
  • 2Zahn R,Hamm CW,Schneider S. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry)[J].American Journal of Cardiology,2005.1302-1308.
  • 3Mauri L,Silbaugh TS,Wolf RE. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts[J].CIRCULATION,2008.1817-1827.
  • 4Lemos PA,Serruys PW,van Domburg RT. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the " real world":the RapamycinEluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry[J].CIRCULATION,2004.190-195.
  • 5Stolker JM,Kennedy KF,Lindsey JB. Predicting restenosis of drug-eluting stents placed in real-world clinical practice:derivation and validation of a risk model from the EVENT registry[J].Circulation: Cardiovascular Imaging,2010.327-334.
  • 6Tsigkas GG,Karantalis V,Hahalis G. Stent restenosis,pathophysiology and treatment options:a 2010 update[J].The Hellenic Journal of Cardiology,2011.149-157.
  • 7Matsushita K,Mahmoodi BK,Woodward M. Comparison of risk prediction using the CKD-EP1 equation and the MDRD study equation for estimated glomerular filtration rate[J].Journal of the American Medical Association,2012.1941-1951.
  • 8Wang JW,Chen YD,Wang CH. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J].CARDIOLOGY,2013.153-160.
  • 9Sales RK,Vargas FS,Capelozzi VL. Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer[J].Respirology,2009.1128-1133.
  • 10Akcakoyun M,Kargin R,Tanalp AC. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation:a prospective study[J].Coronary Artery Disease,2008.337-343.

共引文献13

同被引文献22

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部